Abstract
Objective:
Recently, a new catheter-based 32P brachytherapy source has been developed (College of Chemistry, Sichuan University) for use in high-dose-rate afterloader. This study presents the results of the dosimetric data of the Geant4 Monte Carlo (MC) simulation toolkit for this new 32P brachytherapy source.
Methods:
The new 32P source had dimensions of 0.50-cm length and 0.08-cm diameter and was encapsulated in teflon. In this study, we attempted to obtain dosimetric data for this new source, as required by the formalism proposed by the American Association of Physicists in Medicine reports TG60 and TG149. The source was located in a 30-cm radius theoretical sphere water phantom, and the absorbed dose of the source was calculated using MC code.
Results:
The dosimetric data included the reference absorbed dose rate, the radial dose function in the range of 0.10–0.50 cm at a longitudinal axis, the polynomial function for the radial dose function and the anisotropy function with a θ value of 0–90° in 5° intervals and an r of 0.10–0.35 cm in 0.01-cm intervals. The radial and axial dose profiles and away-along quality assurance table are also calculated for the unsheathed 32P source. The dose rate D(r0,θ0) at the reference point for the unsheathed 32P source is determined to be equal to 1.2660 ± 0.0006 cGy s−1 mCi. The radial dose function of the new 32P source shows good agreement with the other 32P source presented in this work with an average difference of 1.78%.
Conclusion:
Dosimetric data are provided for the new 32P source. These data could be used in treatment-planning systems in clinical practice.
Advances in knowledge:
Provided a new beta-emitting brachytherapy source that is intended for treatment of liver cancer. A dosimetric study of the unsheathed 32P source for which no published dosimetric data existed was performed.
INTRODUCTION
At present, more and more beta-emitting sources are utilized in brachytherapy fields, and many new types of brachytherapy sources are available. Two applications of beta-emitting brachytherapy sources have been proposed: (a) in intravascular brachytherapy—the dosimetric parameters of a 90Sr/90Y source were calculated by Holmes et al1 using an experimental method. Soares et al2 obtained a radial dose function and an anisotropy function from their measurements of an old 90Sr/90Y source in A150 plastic, and these authors also presented the Monte Carlo (MC) results of these dosimetric parameters. (b) In radiotherapy for localized tumours—the 32P source model RIC-100 (developed by RI consultant) has been used for temporary radiation therapy of the spinal dura and other localized tumours, and dosimetric evaluations have been applied to the source with an MCNP5 (Monte Carlo N-particle code 5) MC code by Cohen et al.3 90Y microspheres have recently been used to treat unresectable hepatocellular cancer by Nelson et al.4
According to a lot of pre-clinical experiments for the new 32P source, this new source is well suited for liver cancer. So, we intended to use our new 32P brachytherapy source for liver cancer. The 32P source is a pure beta emitter with a 14.3-day half-life, maximum beta energy of 1.71 MeV and average beta energy of 0.695 MeV.5,6 According to the American Association of Physicists in Medicine (AAPM) TG60/TG149 report recommendations,7,8 dosimetry at distances in the order of 1 mm from the beta-emitting sources are poorly understood, and a better understanding of dosimetry in the millimetre range will help these sources in the development of clinical practice. In addition, TG60 and TG149 are reports that provide the dose parameter formalism for a beta-emitting source, and the reference distance is defined to be 0.20 cm.
The dosimetric parameters of the 32P source have created new challenges in the field of brachytherapy dosimetry. The challenges of the 32P source revealed the following: (a) the dosimetric parameters of the 32P source are interest in the spatial scale of a millimetre or submillimetre; and (b) the parameters are difficult to perform accurately in these close distances owing to the extremely large dose gradients. Although the dosimetric parameters of the 32P brachytherapy source are difficult to obtain, the experimental works and simulation codes were both successful when performed.9–12 Wang et al10 derived the dosimetric data from their modified EGS4 MC code of a 90Sr/90Y source in SS304 stainless steel. Xu et al12 presented the three-dimensional distribution of a 90Sr/90Y intravascular brachytherapy seed by experimental measurement. In this work, we employed Geant4 to derive accurate calculations of the dosimetric parameters of the new catheter-based 32P source, following the formalism proposed by AAPM reports TG60 and TG149 and the quality assurance (QA) purpose of the new 32P source. These dose parameters include the dose rate at the reference point, radial dose functions and anisotropy functions. To ensure calculation accuracy, the present calculation was compared with several calculations reported by other authors.
METHODS AND MATERIALS
Brachytherapy sources
The sizes and materials of the new 32P source were provided by the College of Chemistry, Sichuan University, and the manufacturer tolerances of this new source were ±0.001 cm. The basic sizes and materials of the core and capsules used in the simulation were taken as follows: the active core is composed of a liquid 32P (99.9% H2O and 0.1% 32P) with a density of 1.0 g cm−3 in Table 1. The radioactive material is uniformly distributed in its core, and the energy spectrum of the 32P source is described by Cross et al.13
Table 1.
Composition of the different materials used in the Monte Carlo simulations in this work
| Elements | Teflon (%) | Nylon-12 (%) | Liquid 32P (%) | Air (%) |
|---|---|---|---|---|
| H | 0.1175 | |||
| C | 0.2402 | 0.7305 | 0.0001 | |
| N | 0.071 | 0.7553 | ||
| O | 0.081 | 0.2318 | ||
| F | 0.7598 | |||
| Ar | 0.0128 | |||
| H2O | 0.999 | |||
| 32P | 0.001 | |||
| Density (g cm−3) | 2.2 | 1.2 | 1.0 | 0.0012048 |
The active core is encapsulated. The active core of the source is a cylinder with a length of 0.47 cm and a diameter of 0.08 cm. The capsule material is teflon (24% C and 76% F), with an effective density of 2.2 g cm−3, as shown in Table 1. At the centre of the capsule is a cylinder of 0.42-cm length, 0.08-cm outer diameter and 0.05-cm inner diameter and two semi-spherical endings with 0.08-cm external diameter and 0.05-cm inner diameter on the top and bottom of the cylindrical capsule. The new 32P source is centred inside a cylindrical catheter of nylon-12 (11.75% H, 73.05% C, 7.10% N and 8.10% O) of 0.12-cm external diameter, 0.09-cm internal diameter and a density of 1.2 g cm−3. Gaps between catheters and sources were assumed to be filled with air. A schematic diagram of the new 32P source is presented in Figure 1.
Figure 1.
Schematic design and dimensions of the new 32P source (centimetres).
Dose calculation formalism
The dose calculation formalism for the beta-emitting source, proposed by the AAPM report TG60 in 1999 and TG149 in 2007,7,8 has been followed. This formalism has been described in terms of the polar coordinate system, such as that illustrated in Figure 2. where r denotes the distances from the centre of the active source to the point of interest, r0 is the reference distance, which is defined to be 0.20 cm in this protocol. θ denotes the polar angle of the point of interest, and the reference angle, θ0, is specified to be π/2. β is the angle subtended by the active source with respect to the point of interest P(r, θ). The reference point is represented by P(r0, θ0) in Figure 2. L is the active length of the source (L = 0.47 cm). GL r, θ is the geometry factor, gL(r) is the radial dose function and F(r, θ) is the dose anisotropy function. The dose at any point around the source can be expressed as:
| (1) |
Figure 2.
Polar coordinate system for dose calculation.
For a beta particle-emitting source, the formalism is a little different from that of a photon-emitting source; the air kerma strength Sk and dose rate constant in water λ were replaced by the dose rate D(r0,θ0) at the reference point, which has units of centigray per millicurie. This is because air kerma is applied to only photon-emitting sources and does not exist for beta-emitting sources.
Monte Carlo simulation code
MC particle transport methods are increasingly used in medical physics, in particular for the development of brachytherapy. Popular MC methods in this field are Geant4,14 FLUKA (fluctuating cascade),15 EGS (electron gamma shower),16 MCNP (Monte Carlo N-particle code)17 and PENELOPE (penetration and energy loss of positrons and electrons in matter).9,18 In this article, Geant4 was used to derive all necessary dosimetric data for the new 32P source. The Geant4 code has been developed and successfully applied in both high- and low-energy ranges. In addition, Geant4 allows for the simulation of the passage of primary particles and the produced secondary particles through matter. It can be applied to energies ranging from a few hundred electron volts to up to 1 GeV and with arbitrary materials.
Geant4 (Geant4.9.6.P02 development version, European Organization for Nuclear Research) was developed by the European Organization for Nuclear Research and is based on the C++ language. It requires the user to write each particle and physics model to be included in the simulation. It also provides interaction models for all electromagnetic and nuclear processes relevant for the transport of brachytherapy. The Geant4 physics model selected in this work was a standard electromagnetic interaction model and used the function GetTotalEnergyDeposit, to obtain the dosimetric data. The number of electrons Ne generated in each simulation was Ne = 3 × 108. The electron and the photon cut-off energy were set to 1 keV.
In this study, we assumed that the 32P source was positioned at the centre of a spherical liquid water phantom of 30-cm radius, to provide dose data to water and simulate infinite phantom conditions for r < 1.0 cm. In this way, the phantom was divided into a large number of cells to reduce calculation error, and all dosimetric data in this study were obtained with respect to only the coordinates of r (ranging from 0.10 to 0.35 cm).
The absorbed dose that was used to calculate the radial dose function and anisotropy function was obtained simultaneously in cylindrical (y, z) and spherical (r, θ) coordinates, and the source axis was along the z-axis of the coordinate system, as shown in Figure 2. In cylindrical coordinates, y and z are representatives of the radial and axial coordinates, respectively. In spherical coordinates, r is defined as the distance from the centre of the active region of the source. When z = 0.0, we set up cells at y in the range of 0.10–0.35 cm with increments of 0.01 cm to obtain the absorbed dose D(y,z); subsequently, we used these absorbed doses to obtain the radial dose function. In the spherical coordinate system, we set up cells at the same distances as those used in the cylindrical coordinate system. At the same time, θ ranged from 0° to 90° (angular sampling was taken every 5°) while obtaining the absorbed dose D(r,θ), and then we used the anisotropy function equation to calculate the anisotropy function.
For the new 32P source, the statistical uncertainty of the MC dose D(y,z) depended on the axial position z and the radial position y. When z ≤ 0.25 cm, the statistical uncertainty was within 0.20% for y ≤ 0.40 cm. With increases in the position z, the statistical uncertainty was within 0.31% for y ≤ 0.40 cm.
RESULTS
Unsheathed source
Reference absorbed dose rate
The dose rate at the reference point for the unsheathed source was obtained by using the Geant4 code and it was found to be equal to 3.4216 × 10−10 Gy per electron. The dose rate D(r0,θ0) at the reference point of the unsheathed 32P source in water was 1.2660 ± 0.0006 cGy s−1 mCi, as shown in Table 2, along with the corresponding values calculated by other authors.18–20 The dose rate at the reference point for the 2.70-cm 32P source was calculated to be 0.2312 ± 0.0008 and 0.2150 ± 0.0010 cGy s−1 mCi for Geant4 and PENELOPE by Torres et al.18 The dose at the reference point 0.2185 ± 0.0002 cGy s−1 mCi was calculated by Mourtada et al19 using an EGSnrc code, and the dose rate at the reference point 0.2320 ± 0.0003 cGy s−1 mCi was calculated by Bohm et al20 using an MCNPv4B2 MC code. The value of the dose rate at the reference point for the new 32P source (the length of the active source was 0.47 cm) in this work is higher than that calculated for the old 32P source. These percentage differences were nearly equal to the percentage differences observed for the sizes and materials of the sources.
Table 2.
Comparison of the dose rate at the reference point from this work with calculated values of other authors (using different MC simulation codes)
Radial dose functions
The calculations of the radial dose functions g(r) of the unsheathed 32P source for radial distances from 0.10 to 0.50 cm are presented in Table 3. It must be noted here that at radial distances far from the source (r > 0.35 cm), the radial dose functions have fewer values. When the results of our calculations were compared with those of Torres et al18 for the 2.0-cm-long 32P source in NiTi tubes, differences of 5.33% were observed between radial dose function values only at r = 0.50 cm and they were <2.11% for all other radial distances.
Table 3.
Comparison of the radial dose function [gL(r)] of this work with the calculated values of other authors
| r (cm) | gL(r) (this work) | gL(r) (Torres et al18) | % difference |
|---|---|---|---|
| 0.10 | 1.4020 | 1.4280 | 1.82 |
| 0.11 | 1.3554 | ||
| 0.12 | 1.3217 | ||
| 0.13 | 1.2887 | ||
| 0.14 | 1.2528 | ||
| 0.15 | 1.2132 | 1.2260 | 1.04 |
| 0.16 | 1.1729 | ||
| 0.17 | 1.1319 | ||
| 0.18 | 1.0888 | ||
| 0.19 | 1.0441 | ||
| 0.20 | 1.0000 | 1.0000 | 0.00 |
| 0.21 | 0.9552 | ||
| 0.22 | 0.9110 | ||
| 0.23 | 0.8657 | ||
| 0.24 | 0.8206 | ||
| 0.25 | 0.7767 | 0.7800 | 0.42 |
| 0.26 | 0.7338 | ||
| 0.27 | 0.6925 | ||
| 0.28 | 0.6515 | ||
| 0.29 | 0.6122 | ||
| 0.30 | 0.5740 | 0.5860 | 2.05 |
| 0.35 | 0.4033 | 0.4120 | 2.11 |
| 0.40 | 0.2665 | 0.2700 | 1.30 |
| 0.45 | 0.1656 | 0.1670 | 0.84 |
| 0.50 | 0.0948 | 0.0900 | 5.33 |
gL(r), radial dose function; r, radial distances from 0.10 to 0.50 cm.
The radial dose function, gL(r), also fit over the range of 0.10 ≤ r≤ 0.50 cm using a fifth-order polynomial function, as presented in Figure 3. The polynomial function is shown in Equation (2). The values of the fitted parameters in Equation 2 were as follows: R2 1, a0 = 0.01771, a1 = −0.44983, a2 = 5.68668, a3 = −11.82432, a4 = 2.79516, a5 = 5.56452 and a6 = 2.56705. The overall accuracies of the fits were excellent, and the fits were based on the polynomial exhibited maximum of <0.20%.
| (2) |
Figure 3.
Radial dose functions calculated for the new 32P source without catheter and the old 32P source. The line is the polynomial fit of order 5 for the new 32P source. cm, centimetre.
Dose profiles
The following is the two-dimensional dose profiles D(y,z) of the unsheathed 32P source in water. Figure 4 shows the radial dose profiles D(y,z) for selected axial distances of z = 0.0, 0.10, 0.25, 0.40 and 0.50 cm. It can be observed that for 0 < z < L/2 (L = 0.47 cm, which is the active length of the source), the radial dose values are higher than those for z > L/2. Furthermore, the radial dose decreases more sharply than for other regions; for y > 0.25 cm, as y increases, the dose fall-off becomes shallower. The axial dose profiles D(y,z) of the 32P source at radial distances y = 0.0, 0.10, 0.15, 0.25, 0.40 and 0.50 cm are presented in Figure 5. The results show that the axial doses at y = 0.10 and 0.15 cm are higher and sharper than for other positions. Beyond this region, the dose declines in an approximately exponential way. In addition, for z > L/2, the decline of doses is smoother than for other positions. The dose distributions were normalized by the maximum dose of the axial and radial distances at 0.20 cm, respectively.
Figure 4.
Radial dose profiles D(y,z) with a different radial position z for the unsheathed 32P source in water. cm, centimetre.
Figure 5.
Axial dose profiles D(y,z) with a different radial position y for the unsheathed 32P source in water. cm, centimetre.
Anisotropy functions
In Table 4 and Figure 6, full data for the anisotropy functions F(r,θ) are presented for radial distances r = 0.10–0.35 cm and polar angles θ = 0°–90°. Anisotropy function values were not calculated for points located inside the source volume. A feature of the anisotropy functions is that F(r,θ) of a beta-emitting source has more points, >1.0. Thus, we can observe that the effective distance of the 32P source is less than 0.35 cm; beyond this distance, we can ignore the absorbed dose.
Table 4.
Anisotropy function calculated for the unsheathed 32P source
| Angle (°) | Radial distance (cm) |
|||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.10 | 0.11 | 0.12 | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.20 | 0.21 | 0.22 | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 | 0.28 | 0.29 | 0.30 | 0.31 | 0.32 | 0.33 | 0.34 | 0.35 | |
| 0 | 1.332 | 1.454 | 1.547 | 1.627 | 1.699 | 1.745 | 1.819 | 1.881 | 1.960 | 2.049 | ||||||||||||||||
| 5 | 1.414 | 1.481 | 1.551 | 1.615 | 1.671 | 1.729 | 1.784 | 1.841 | 1.902 | 1.989 | ||||||||||||||||
| 10 | 1.491 | 1.495 | 1.524 | 1.573 | 1.623 | 1.676 | 1.730 | 1.778 | 1.839 | 1.899 | 1.985 | |||||||||||||||
| 15 | 1.308 | 1.316 | 1.346 | 1.373 | 1.402 | 1.410 | 1.423 | 1.427 | 1.443 | 1.468 | 1.496 | 1.536 | 1.578 | 1.622 | 1.666 | 1.713 | 1.758 | 1.815 | 1.867 | 1.950 | ||||||
| 20 | 1.186 | 1.167 | 1.183 | 1.205 | 1.222 | 1.249 | 1.279 | 1.308 | 1.340 | 1.367 | 1.394 | 1.417 | 1.447 | 1.476 | 1.502 | 1.537 | 1.572 | 1.610 | 1.648 | 1.689 | 1.728 | 1.772 | 1.821 | 1.900 | ||
| 25 | 1.100 | 1.105 | 1.118 | 1.124 | 1.143 | 1.165 | 1.190 | 1.218 | 1.248 | 1.276 | 1.308 | 1.336 | 1.364 | 1.391 | 1.421 | 1.453 | 1.479 | 1.512 | 1.545 | 1.577 | 1.607 | 1.644 | 1.677 | 1.719 | 1.758 | 1.831 |
| 30 | 1.071 | 1.076 | 1.087 | 1.103 | 1.124 | 1.145 | 1.170 | 1.195 | 1.222 | 1.246 | 1.276 | 1.301 | 1.328 | 1.355 | 1.384 | 1.410 | 1.435 | 1.462 | 1.495 | 1.526 | 1.551 | 1.584 | 1.611 | 1.648 | 1.686 | 1.750 |
| 35 | 1.050 | 1.059 | 1.071 | 1.086 | 1.104 | 1.121 | 1.143 | 1.164 | 1.187 | 1.210 | 1.235 | 1.256 | 1.281 | 1.302 | 1.328 | 1.352 | 1.373 | 1.396 | 1.424 | 1.450 | 1.471 | 1.497 | 1.523 | 1.553 | 1.586 | 1.645 |
| 40 | 1.041 | 1.049 | 1.061 | 1.072 | 1.088 | 1.105 | 1.122 | 1.140 | 1.161 | 1.179 | 1.199 | 1.219 | 1.239 | 1.258 | 1.280 | 1.299 | 1.318 | 1.339 | 1.357 | 1.380 | 1.398 | 1.421 | 1.443 | 1.469 | 1.495 | 1.549 |
| 45 | 1.036 | 1.038 | 1.047 | 1.057 | 1.069 | 1.082 | 1.096 | 1.112 | 1.128 | 1.141 | 1.160 | 1.176 | 1.193 | 1.210 | 1.226 | 1.241 | 1.256 | 1.272 | 1.288 | 1.305 | 1.319 | 1.338 | 1.354 | 1.376 | 1.397 | 1.449 |
| 50 | 1.033 | 1.029 | 1.035 | 1.042 | 1.052 | 1.061 | 1.073 | 1.084 | 1.096 | 1.108 | 1.121 | 1.134 | 1.147 | 1.158 | 1.171 | 1.186 | 1.195 | 1.208 | 1.223 | 1.236 | 1.249 | 1.261 | 1.271 | 1.292 | 1.307 | 1.356 |
| 55 | 1.027 | 1.021 | 1.024 | 1.027 | 1.031 | 1.033 | 1.035 | 1.049 | 1.142 | 1.125 | 1.134 | 1.144 | 1.157 | 1.168 | 1.182 | 1.194 | 1.203 | 1.216 | 1.229 | 1.242 | 1.253 | 1.266 | 1.279 | 1.299 | 1.323 | 1.398 |
| 60 | 1.020 | 1.019 | 1.019 | 1.018 | 1.018 | 1.018 | 1.033 | 1.106 | 1.099 | 1.103 | 1.113 | 1.122 | 1.133 | 1.142 | 1.154 | 1.164 | 1.172 | 1.182 | 1.193 | 1.205 | 1.213 | 1.225 | 1.235 | 1.254 | 1.277 | 1.347 |
| 65 | 0.991 | 0.983 | 1.003 | 0.998 | 0.998 | 1.007 | 1.076 | 1.057 | 1.060 | 1.065 | 1.073 | 1.081 | 1.089 | 1.097 | 1.105 | 1.113 | 1.119 | 1.128 | 1.138 | 1.146 | 1.153 | 1.163 | 1.173 | 1.190 | 1.211 | 1.291 |
| 70 | 1.013 | 0.995 | 0.990 | 0.986 | 0.992 | 1.057 | 1.032 | 1.031 | 1.035 | 1.039 | 1.047 | 1.053 | 1.059 | 1.065 | 1.073 | 1.080 | 1.084 | 1.091 | 1.100 | 1.108 | 1.114 | 1.123 | 1.132 | 1.151 | 1.175 | 1.265 |
| 75 | 1.015 | 0.995 | 0.988 | 0.985 | 0.984 | 1.055 | 1.022 | 1.019 | 1.022 | 1.023 | 1.028 | 1.032 | 1.038 | 1.042 | 1.048 | 1.053 | 1.056 | 1.062 | 1.069 | 1.076 | 1.080 | 1.089 | 1.098 | 1.116 | 1.142 | 1.243 |
| 80 | 1.012 | 0.999 | 0.995 | 0.994 | 0.994 | 1.055 | 1.024 | 1.020 | 1.020 | 1.021 | 1.026 | 1.029 | 1.033 | 1.036 | 1.041 | 1.045 | 1.048 | 1.054 | 1.058 | 1.064 | 1.070 | 1.078 | 1.088 | 1.107 | 1.134 | 1.237 |
| 85 | 1.033 | 1.022 | 1.018 | 1.016 | 1.014 | 1.077 | 1.038 | 1.032 | 1.032 | 1.032 | 1.035 | 1.037 | 1.042 | 1.043 | 1.049 | 1.053 | 1.055 | 1.060 | 1.065 | 1.071 | 1.075 | 1.084 | 1.095 | 1.117 | 1.148 | 1.267 |
| 90 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 |
Figure 6.
Anisotropy function calculated for the unsheathed 32P source for selected distances.
An along-away table for QA purposes is presented in Table 5. For this table, the longitudinal direction is equal to the y-axis (cm) and the transverse direction is equal to the z-axis (cm), as we can see in Figure 2. The new 32P source is symmetric about the transverse and vertical axes; therefore, the QA values were tabulated over the range of 0.10 ≤ y ≤ 0.4 and 0.0 ≤ z ≤ 0.40 cm.
Table 5.
Quality assurance away-along data (gray per minute millicurie) for the unsheathed 32P sources
| y/cm | z/cm |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | 0.10 | 0.12 | 0.14 | 0.16 | 0.18 | 0.20 | 0.22 | 0.24 | 0.26 | 0.28 | 0.30 | 0.32 | 0.34 | 0.36 | 0.38 | 0.40 | |
| 0.10 | 2.855 | 2.687 | 2.590 | 2.470 | 2.301 | 2.101 | 1.870 | 1.587 | 1.311 | 1.068 | 0.835 | 0.655 | 0.515 | 0.395 | 0.307 | 0.243 | 0.185 |
| 0.12 | 2.131 | 1.975 | 1.893 | 1.806 | 1.669 | 1.528 | 1.380 | 1.179 | 0.995 | 0.844 | 0.668 | 0.536 | 0.437 | 0.335 | 0.263 | 0.215 | 0.162 |
| 0.14 | 1.628 | 1.494 | 1.431 | 1.362 | 1.252 | 1.148 | 1.051 | 0.904 | 0.776 | 0.676 | 0.542 | 0.443 | 0.369 | 0.287 | 0.229 | 0.188 | 0.144 |
| 0.16 | 1.257 | 1.145 | 1.094 | 1.042 | 0.956 | 0.879 | 0.812 | 0.703 | 0.610 | 0.541 | 0.441 | 0.365 | 0.310 | 0.243 | 0.196 | 0.164 | 0.126 |
| 0.18 | 0.977 | 0.884 | 0.842 | 0.805 | 0.738 | 0.682 | 0.633 | 0.550 | 0.482 | 0.434 | 0.357 | 0.299 | 0.258 | 0.204 | 0.167 | 0.140 | 0.109 |
| 0.20 | 0.761 | 0.687 | 0.654 | 0.626 | 0.573 | 0.532 | 0.496 | 0.432 | 0.382 | 0.347 | 0.288 | 0.244 | 0.213 | 0.170 | 0.140 | 0.119 | 0.093 |
| 0.22 | 0.596 | 0.536 | 0.510 | 0.488 | 0.447 | 0.416 | 0.390 | 0.341 | 0.303 | 0.278 | 0.232 | 0.198 | 0.175 | 0.141 | 0.116 | 0.100 | 0.078 |
| 0.24 | 0.466 | 0.419 | 0.399 | 0.382 | 0.349 | 0.326 | 0.307 | 0.269 | 0.240 | 0.222 | 0.186 | 0.161 | 0.142 | 0.116 | 0.096 | 0.083 | 0.066 |
| 0.26 | 0.364 | 0.327 | 0.312 | 0.299 | 0.273 | 0.256 | 0.241 | 0.212 | 0.190 | 0.177 | 0.149 | 0.129 | 0.116 | 0.094 | 0.079 | 0.069 | 0.054 |
| 0.28 | 0.285 | 0.256 | 0.244 | 0.233 | 0.213 | 0.200 | 0.189 | 0.167 | 0.151 | 0.141 | 0.119 | 0.103 | 0.093 | 0.076 | 0.064 | 0.056 | 0.045 |
| 0.30 | 0.223 | 0.200 | 0.190 | 0.182 | 0.166 | 0.157 | 0.148 | 0.131 | 0.118 | 0.111 | 0.094 | 0.082 | 0.074 | 0.061 | 0.052 | 0.045 | 0.036 |
| 0.32 | 0.173 | 0.155 | 0.148 | 0.142 | 0.130 | 0.122 | 0.116 | 0.102 | 0.093 | 0.087 | 0.075 | 0.066 | 0.059 | 0.049 | 0.042 | 0.037 | 0.029 |
| 0.34 | 0.135 | 0.121 | 0.115 | 0.110 | 0.101 | 0.095 | 0.090 | 0.080 | 0.073 | 0.068 | 0.059 | 0.052 | 0.047 | 0.039 | 0.033 | 0.029 | 0.023 |
| 0.36 | 0.104 | 0.093 | 0.089 | 0.084 | 0.078 | 0.074 | 0.070 | 0.062 | 0.057 | 0.053 | 0.046 | 0.040 | 0.037 | 0.030 | 0.026 | 0.023 | 0.018 |
| 0.38 | 0.080 | 0.072 | 0.069 | 0.065 | 0.059 | 0.057 | 0.054 | 0.047 | 0.044 | 0.041 | 0.035 | 0.032 | 0.028 | 0.024 | 0.020 | 0.018 | 0.014 |
| 0.40 | 0.061 | 0.055 | 0.052 | 0.049 | 0.045 | 0.043 | 0.040 | 0.036 | 0.033 | 0.031 | 0.027 | 0.024 | 0.021 | 0.018 | 0.016 | 0.014 | 0.011 |
Sheathed source
Here, we show the effect of the catheter on the dosimetric data. Table 6 shows the comparison of depth doses for the sources sheathed and unsheathed by the catheter. As we can see, our calculated depth dose rate values for the sheathed source agreed with the calculated depth dose rate values for the unsheathed source . However, the source sheathed by the catheter shows an increase in the depth dose rate on the longitudinal axis.
Table 6.
Depth dose rates (in centigray per second per millicurie) calculated for the sheathed 32P source, , and unsheathed source,
| r (cm) | ||
|---|---|---|
| 0.10 | 4.7916 | 4.8266 |
| 0.15 | 2.3719 | 2.4013 |
| 0.20 | 1.2660 | 1.2831 |
| 0.25 | 0.6856 | 0.6977 |
| 0.30 | 0.3719 | 0.3786 |
| 0.35 | 0.1993 | 0.2030 |
| 0.40 | 0.1035 | 0.1064 |
| 0.45 | 0.0518 | 0.0534 |
| 0.50 | 0.0244 | 0.0247 |
r, radial distance.
Figure 7 shows the relative difference between the depth dose rate value for the source sheathed Dcath (r, z0) and unsheathed D(r, z0) in this work using Equation 3. The study shows that an unsheathed source produces a slightly smaller modification of the dose in water than a sheathed source. When r ≤ 0.23 cm, the relative difference is always within 2.0% and is 2.0–3.2% for the positions of 0.30 < r ≤ 0.50 cm.
| (3) |
Figure 7.
The relative difference between the depth dose rates calculated for the sheathed 32P source, , and the unsheathed source, . cm, centimetre.
CONCLUSION
Many new types of brachytherapy sources are becoming available. Before any of these sources can be used in clinical practice, their dosimetric parameters must be calculated by using the MC code. The main purpose of the present work was to use the MC simulation code Geant4 to derive all the necessary dosimetric parameters (reference absorbed dose rate, radial dose function and anisotropy function) for the new 32P brachytherapy source, based on the dose calculation formalism recommended by AAPM TG60 and TG149. The dose distribution and QA purpose are also calculated for the new 32P source. These parameters are shown in this work in the configuration of both a graph and a table. Furthermore, these dosimetric parameters for the new 32P source did not exist previously. All of the statistical uncertainties at distances of z ≤ 0.40 cm and y ≤ 0.40 cm were below 0.31%.
The results of this study have been compared with those of several published works. Differences in the sizes and materials of the new 32P source do not seem to affect radial dose function calculations. The decreased length of the new 32P source design (the active length of the new source was 0.47 cm) resulted in increased reference absorbed dose rate compared with the old 32P source (the active length of the old source was 2.70 cm). The presence of the sheathed source produces an increase of within 3.2% in the depth dose rate on the longitudinal axis. These differences could produce non-negligible modifications in the clinical use of the sources. At present, the new 32P brachytherapy source has been applied in the Fonics plan treatment system developed by a Chinese company (Qilin Co., Ltd).
Contributor Information
Junxiang Wu, Email: 13219873330@163.com.
Jing Huang, Email: 854058679@qq.com.
Fengxiang Long, Email: 844167125@qq.com.
Chengkai Wang, Email: 78215502@qq.com.
Zhangwen Wu, Email: wuzhangwen@scu.edu.cn.
Chengjun Gou, Email: Chengj.Gou@263.net.
REFERENCES
- 1.Holmes SM, DeWerd LA, Micka JA. Experimental determination of the radial dose function of 90Sr/90Y IVBT sources. Med Phys 2006; 33: 3225–33. doi: 10.1118/1.2256068 [DOI] [PubMed] [Google Scholar]
- 2.Soares CG, Halpern DG, Wang CK. Calibration and characterization of beta-particle sources for intravascular brachytherapy. Med Phys 1998; 25: 339–46. doi: 10.1118/1.598204 [DOI] [PubMed] [Google Scholar]
- 3.Cohen GN, Munro JJ, 3rd, Kirov A, Losasso T, Yamada Y, Williamson M, et al. 32P brachytherapy conformal source model RIC-100 for high-dose-rate treatment of superficial disease: Monte Carlo calculations, diode measurements, and clinical implementation. Int J Radiat Oncol Biol Phys 2014; 88: 746–52. doi: 10.1016/j.ijrobp.2013.11.006 [DOI] [PubMed] [Google Scholar]
- 4.Nelson K, Vause PE, jr, Koropova P. Post-mortem considerations of Yttrium-90 (90Y) microsphere therapy procedures. Health Phys 2008; 95: S156–61. doi: 10.1097/01.HP.0000318887.65414.15 [DOI] [PubMed] [Google Scholar]
- 5.Walichiewicz P, Petelenz B, Wilczek K, Jacheć W, Jochem J, Tomasik A, et al. 32P liquid sources—comparison of the effectiveness of postangioplasty versus poststenting intravascular brachytherapy in hypercholesterolemic rabbits. Adjunctly implanted titanium stent does not attenuate the effect of endovascular irradiation. Cardiovasc Radiat Med 2003; 4: 64–8. doi: 10.1016/S1522-1865(03)00145-8 [DOI] [PubMed] [Google Scholar]
- 6.Wang R, Li XA. Monte Carlo characterization of a 32P source for intravascular brachytherapy. Med Phys 2001; 28: 1776–85. doi: 10.1118/1.1388222 [DOI] [PubMed] [Google Scholar]
- 7.Nath R, Amols H, Coffey C, Duggan D, Jani S, Li Z, et al. Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 60. American Association of Physicists in Medicine. Med Phys 1999; 26: 119–52. [DOI] [PubMed] [Google Scholar]
- 8.Chiu-Tsao S, Schaart DR, Soares CG, Nath R; AAPM Therapy Physics Committee Task Group No 149. Dose calculation formalisms and consensus dosimetry parameters for intravascular brachytherapy dosimetry: recommendations of the AAPM Therapy Physics Committee Task Group No. 149. Med Phys 2007; 34: 4126–57. doi: 10.1118/1.2767184 [DOI] [PubMed] [Google Scholar]
- 9.Asenjo J, Fernández-Varea JM, Sánchez-Reyes A. Characterization of a high-dose-rate 90Sr–90Y source for intravascular brachytherapy by using the Monte Carlo code PENELOPE. Phys Med Biol 2002; 47: 697–711. doi: 10.1088/0031-9155/47/5/301 [DOI] [PubMed] [Google Scholar]
- 10.Wang R, Li XA. A Monte Carlo calculation of dosimetric parameters of 90Sr/90Y and 192Ir SS sources for intravascular brachytherapy. Med Phys 2000; 27: 2528–35. doi: 10.1118/1.1319374 [DOI] [PubMed] [Google Scholar]
- 11.Massillon-JL G, Minniti R, Mitch MG, Maryanski MJ, Soares CG. The use of gel dosimetry to measure the 3D dose distribution of a 90Sr/90Y intravascular brachytherapy seed. Phys Med Biol 2009; 54: 1661–72. doi: 10.1088/0031-9155/54/6/017 [DOI] [PubMed] [Google Scholar]
- 12.Xu Z, Almond PR, Deasy JO. The dose distribution produced by a 32P source for endovascular irradiation. Int J Radiat Oncol Biol Phys 1996; 36: 933–9. doi: 10.1016/S0360-3016(96)00300-8 [DOI] [PubMed] [Google Scholar]
- 13.Cross WG, Ing H, Freedman N. A short atlas of beta-ray spectra. Phys Med Biol 1983; 28: 1251–60. doi: 10.1088/0031-9155/28/11/005 [DOI] [Google Scholar]
- 14.Agostinelli S, Allison J, Amako K, Apostolakis J, Araujo H, Arce P, et al. Geant4—a simulation toolkit. Nucl Instrum Methods Phys Res A 2003; 506: 250–303. doi: 10.1016/S0168-9002(03)01368-8 [DOI] [Google Scholar]
- 15.Ballarini F, Battistoni G, Campanella M, Carboni M, Cerutti F, Empl A, et al. The FLUKA code: an overview. J Phys Conf Ser 2006; 41: 151–60. doi: 10.1088/1742-6596/41/1/014 [DOI] [Google Scholar]
- 16.Wang R, Sloboda RS. EGS4 dosimetry calculations for cylindrically symmetric brachytherapy sources. Med Phys 1996; 23: 1459–65. doi: 10.1118/1.597728 [DOI] [PubMed] [Google Scholar]
- 17.Chiu-Tsao S, Fang FX, Ahumbay E, Shih J. Dosimetric parameters for 192Ir and 125I seeds for intravascular brachytherapy. Med Phys 1997; 24: 994. [Google Scholar]
- 18.Torres J, Buades MJ, Almansa JF, Guerrero R, Lallena AM. Dosimetry characterization of 32P intravascular brachytherapy source wires using Monte Carlo codes PENELOPE and GEANT4. Med Phys 2004; 31: 296–304. doi: 10.1118/1.1637970 [DOI] [PubMed] [Google Scholar]
- 19.Mourtada FA, Soares CG, Seltzer SM, Lott SH. Dosimetry characterization of 32P catheter-based vascular brachytherapy source wire. Med Phys 2000; 27: 1770–6. doi: 10.1118/1.1286551 [DOI] [PubMed] [Google Scholar]
- 20.Bohm TD, Mourtada FA, Das RK. Dose rate table for a 32P intravascular brachytherapy source from Monte Carlo calculations. Med Phys 2001; 28: 1770–5. doi: 10.1118/1.1384459 [DOI] [PubMed] [Google Scholar]







